Brief: LifeMD Expands Primary Care Platform’S Diagnostic Capabilities With New At-Home Screening Kits For Early Warning Signs Of Cancer
14/09/2022 14:00
Sept 14 (Reuters) - LifeMD Inc LFMD.O :
* LIFEMD EXPANDS PRIMARY CARE PLATFORM’S DIAGNOSTIC
CAPABILITIES
WITH NEW AT-HOME SCREENING KITS FOR EARLY WARNING SIGNS OF
CANCER
Source text for Eikon: ID:nGNX1HPjnc
Further company coverage: LFMD.O
(Reporting by Pratik Jain)
((Pratik.Jain@thomsonreuters.com;))
Recent news on LifeMD
See all newsLifeMD Inc reports results for the quarter ended June 30 - Earnings Summary
LifeMD Q2 revenue misses estimates as shift to branded GLP-1 therapies weighs
Brief: LifeMD Inc Q2 Revenue USD 47.3 Million Vs. IBES Estimate USD 49.2 Million
LifeMD Inc expected to post a loss of 15 cents a share - Earnings Preview
LifeMD Q1 revenue beats estimates on record telehealth subscriber additons